Nele Van Dessel
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2018First federal award
$2.0MFederal grants as PI5 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
5 awards · $2.0M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Jan 6, 2021 | NSF | SBIR Phase II SBIR Phase II: A bacterial intracellular delivery platform for liver cancer | $1.0M | ERNEST PHARMACEUTICALS LLC |
| Sep 21, 2020 | NIH | SBIR Phase I Bacterial delivery of pro-apoptotic proteins in advanced hepatocellular carcinoma. | $284K | ERNEST PHARMACEUTICALS LLC |
| Sep 6, 2018 | NIH | SBIR Phase I Bacterial delivery of phosphatase antagonists to metastatic breast cancer | $224K | ERNEST PHARMACEUTICALS LLC |
| Sep 6, 2018 | NIH | SBIR Phase I Bacterial delivery of phosphatase antagonists to metastatic breast cancer | $224K | ERNEST PHARMACEUTICALS LLC |
| May 21, 2018 | NSF | SBIR Phase I SBIR Phase I: A bacterial intracellular delivery platform for liver cancer | $225K | ERNEST PHARMACEUTICALS LLC |
Peer ranks
Federal funding#1,080
Awards as PI#417
Patents#273
Companies
- ERNEST PHARMACEUTICALS LLCLinked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.